Journal of Neuroimmune Pharmacology
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 6.1 | Q1 | 88.2% | 1.458 | Q1 | 91.6% |
| 2024 | 3.5 | Q2 | 70.0% | 1.251 | Q1 | 89.2% |
| 2023 | 5.2 | Q1 | 89.2% | 1.396 | Q1 | 91.8% |
| 2022 | 6.2 | Q1 | 90.4% | 1.308 | Q1 | 91.2% |
| 2021 | 7.3 | Q1 | 92.7% | 1.381 | Q1 | 92.0% |
| 2020 | — | — | 1.219 | Q1 | 89.2% | |
| 2019 | — | — | 1.235 | Q1 | 89.7% | |
| 2018 | — | — | 1.333 | Q1 | 90.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1557-1904
ISSN
1557-1890
country
UScoverage
2006-2026